FDA Approves Bysanti for Bipolar and Schizophrenia
Millions living with serious mental illness just got a new treatment option. The FDA approved Bysanti, offering hope for those managing bipolar 1 disorder and schizophrenia.
Find uplifting stories about heroes, innovations, and solutions
11 results for "schizophrenia"
Millions living with serious mental illness just got a new treatment option. The FDA approved Bysanti, offering hope for those managing bipolar 1 disorder and schizophrenia.

The FDA just approved BYSANTI, a new medication offering hope to millions of Americans living with schizophrenia and bipolar I disorder. Built on more than a decade of proven safety data, this treatment represents a faster path to innovation in mental health care.

Researchers in Israel used deep-brain stimulation to dramatically reduce hallucinations in patients with treatment-resistant schizophrenia, opening a new frontier for the 30% who don't respond to medication. One patient said the voices that controlled his life finally became quiet.

Scientists in Israel successfully reversed schizophrenia symptoms in lab trials using targeted brain stimulation, offering hope for millions who don't respond to current treatments. The breakthrough could transform care for one-third of the world's 21 million schizophrenia patients.

Three mothers whose sons developed schizophrenia are fighting to change a broken mental health system. Their advocacy is creating real solutions for families navigating one of healthcare's toughest challenges.

A groundbreaking study shows adding brexpiprazole to existing treatments helps people with schizophrenia think faster and process information better. The discovery opens new doors for treating one of the condition's most disabling symptoms that affects daily life and work.

Researchers at NYU have pinpointed exactly where those sudden flashes of insight happen in your brain, solving a mystery that's puzzled scientists for decades. The discovery could help millions with conditions like schizophrenia and Parkinson's disease.
A Sydney supported housing program that helps homeless people with mental illness stay on medication is getting attention after a coroner's inquest. The model costs less than doing nothing and could prevent future tragedies.

Researchers have created the most detailed brain organoid yet, complete with a blood vessel system that mirrors the real human brain. This breakthrough could unlock new understanding of autism, schizophrenia, and dementia.

A groundbreaking medication approved in 2024 treats schizophrenia through an entirely new approach, targeting brain receptors never before used in mental health treatment. The drug shows promise for managing symptoms without the severe metabolic side effects that have plagued patients for decades.

Scientists at Johns Hopkins discovered that a "dormant" brain protein is actually a powerful switch that could lead to new treatments for anxiety, schizophrenia, and movement disorders. The breakthrough reveals how these mysterious proteins actively control how brain cells communicate.